AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that support a wide moat. The strong replenishment of new drugs sets ...
Why are Ripple investors jumping ship to Lightchain AI to outsmart market mayhem? With over $17.3 million raised at a presale ...